Keppra 100mg/ml concentrate for solution for infusion
- Name:
Keppra 100mg/ml concentrate for solution for infusion
- Company:
UCB (Pharma) Ireland Limited
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may be renewed (B)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 13/01/21

Click on this link to Download PDF directly
UCB (Pharma) Ireland Limited
 Ireland Limited.jpg)
Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 13 January 2021 PIL
Reasons for updating
- Change to section 3 - how to take/use
Free text change information supplied by the pharmaceutical company
Update to recommend the same dosing for monotherapy and adjunctive therapy – SmPC Section 4.2 - PIL section 3
Updated on 13 January 2021 SPC
Reasons for updating
- Change to section 4.2 - Posology and method of administration
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Update to recommend the same dosing for monotherapy and adjunctive therapy – SmPC Section 4.2
Updated on 20 October 2020 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
Free text change information supplied by the pharmaceutical company
Correction to the stated Manufacturer in section 6
Updated on 20 October 2020 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Free text change information supplied by the pharmaceutical company
Addition of warning and adverse reaction of QT Prolongation – Section 2 & 4
Updated on 20 October 2020 SPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Addition of warning and adverse reaction of QT Prolongation – Section 2 & 4
Updated on 31 July 2020 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Free text change information supplied by the pharmaceutical company
Addition of the warning and ADR on “Worsening Seizures”
Updated on 31 July 2020 SPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Addition of the warning and ADR on “Worsening Seizures”
Updated on 18 October 2019 SPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 18 October 2019 PIL
Reasons for updating
- Change to section 4 - possible side effects
Updated on 1 April 2019 PIL
Reasons for updating
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 29 March 2019 SPC
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 13 March 2019 PIL
Reasons for updating
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 3 - how to take/use
- Change to section 4 - possible side effects
Updated on 13 March 2019 SPC
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.8 - Undesirable effects
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Pregnancy wording update, dysgeusia, pregnancy malformation update and gait disturbance
Updated on 2 January 2017 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 23 December 2016 PIL
Reasons for updating
- New PIL for new product
Updated on 23 December 2016 PIL
Reasons for updating
- Change to section 6 - date of revision
- Change to other sources of information section
Updated on 7 September 2015 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change of contraindications
- Change to side-effects
- Change to drug interactions
- Change to information about drinking alcohol
- Change to information about pregnancy or lactation
- Change to further information section
- Change to date of revision
- Change to dosage and administration
Updated on 24 March 2014 PIL
Reasons for updating
- Change to side-effects
Updated on 9 January 2014 PIL
Reasons for updating
- Change to side-effects
Updated on 10 August 2012 PIL
Reasons for updating
- Change to side-effects
Updated on 16 December 2011 PIL
Reasons for updating
- Correction of spelling/typing errors
Updated on 28 November 2011 PIL
Reasons for updating
- Change to side-effects
Updated on 19 October 2011 PIL
Reasons for updating
- Change of manufacturer
- Change to side-effects
Updated on 13 May 2011 PIL
Reasons for updating
- Change to MA holder contact details
Updated on 6 December 2010 PIL
Reasons for updating
- Change to improve clarity and readability
Updated on 6 April 2010 PIL
Reasons for updating
- Change to dosage and administration
Updated on 10 March 2009 PIL
Reasons for updating
- Change to warnings or special precautions for use
Updated on 18 February 2008 PIL
Reasons for updating
- Change of manufacturer
Updated on 9 August 2007 PIL
Reasons for updating
- Change of manufacturer
Updated on 5 February 2007 PIL
Reasons for updating
- Change to, or new use for medicine
Updated on 14 August 2006 PIL
Reasons for updating
- New PIL for new product